Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

2.2 Citations (2)

Originally described in: A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration.
Pariente N, Morizono K, Virk MS, Petrigliano FA, Reiter RE, Lieberman JR, Chen IS Mol Ther. 2007 Nov;15(11):1973-81. Epub 2007 Jul 24. PubMed Journal

Articles Citing 2.2

Articles
A novel dendritic cell-targeted lentiviral vector, encoding Ag85A-ESAT6 fusion gene of Mycobacterium tuberculosis, could elicit potent cell-mediated immune responses in mice. Shakouri M, Moazzeni SM, Ghanei M, Arashkia A, Etemadzadeh MH, Azadmanesh K. Mol Immunol. 2016 Jul;75:101-11. doi: 10.1016/j.molimm.2016.04.014. Epub 2016 Jun 3. PubMed
Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature. Ahani R, Roohvand F, Cohan RA, Etemadzadeh MH, Mohajel N, Behdani M, Shahosseini Z, Madani N, Azadmanesh K. Mol Biotechnol. 2016 Nov;58(11):738-747. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.